These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 25799985)

  • 1. Cardiology: A big-hearted molecule.
    Kuhn M
    Nature; 2015 Mar; 519(7544):416-7. PubMed ID: 25799985
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiovascular disease: PDE9A inhibition mends broken hearts.
    Bray N
    Nat Rev Drug Discov; 2015 May; 14(5):310. PubMed ID: 25907345
    [No Abstract]   [Full Text] [Related]  

  • 3. Phosphodiesterase 9A controls nitric-oxide-independent cGMP and hypertrophic heart disease.
    Lee DI; Zhu G; Sasaki T; Cho GS; Hamdani N; Holewinski R; Jo SH; Danner T; Zhang M; Rainer PP; Bedja D; Kirk JA; Ranek MJ; Dostmann WR; Kwon C; Margulies KB; Van Eyk JE; Paulus WJ; Takimoto E; Kass DA
    Nature; 2015 Mar; 519(7544):472-6. PubMed ID: 25799991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac actions of atrial natriuretic peptide: new visions of an old friend.
    Kuhn M
    Circ Res; 2015 Apr; 116(8):1278-80. PubMed ID: 25858056
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyclic GMP-hydrolyzing phosphodiesterases.
    Francis SH; Corbin JD; Bischoff E
    Handb Exp Pharmacol; 2009; (191):367-408. PubMed ID: 19089337
    [No Abstract]   [Full Text] [Related]  

  • 6. [Phosphodiesterases of cyclic GMP].
    Wróblewska H; Gorczyca WA
    Postepy Hig Med Dosw; 2001; 55(5):611-27. PubMed ID: 11795198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microdomain switch of cGMP-regulated phosphodiesterases leads to ANP-induced augmentation of β-adrenoceptor-stimulated contractility in early cardiac hypertrophy.
    Perera RK; Sprenger JU; Steinbrecher JH; Hübscher D; Lehnart SE; Abesser M; Schuh K; El-Armouche A; Nikolaev VO
    Circ Res; 2015 Apr; 116(8):1304-11. PubMed ID: 25688144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term regulation of PDE4 activity.
    Manganiello V
    Br J Pharmacol; 2002 Jun; 136(3):339-40. PubMed ID: 12023934
    [No Abstract]   [Full Text] [Related]  

  • 9. Prostacyclin-induced relaxations of small porcine pulmonary arteries are enhanced by the basal release of endothelium-derived nitric oxide through an effect on cyclic GMP-inhibited-cyclic AMP phosphodiesterase.
    Zellers TM; Wu YQ; McCormick J; Vanhoutte PM
    Acta Pharmacol Sin; 2000 Feb; 21(2):131-8. PubMed ID: 11263259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-Km cyclic AMP phosphodiesterase from human platelets. Stimulation of activity by phosphorylation of the enzyme and affinity labeling of the active site.
    Grant PG; DeCamp DL; Bailey JM; Colman RF; Colman RW
    Adv Second Messenger Phosphoprotein Res; 1992; 25():73-85. PubMed ID: 1313273
    [No Abstract]   [Full Text] [Related]  

  • 11. [Activity of protein kinases and phosphodiesterases in the cell cycle of Ph. polycephalum].
    Trakht NN; Grozdova ID; Severin ES; Gnuchev NV
    Biokhimiia; 1980 Apr; 45(4):636-43. PubMed ID: 6246974
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyclic nucleotides and cyclic nucleotide phosphodiesterases in kidneys from rats with experimental diabetes.
    Hoskins B; Luong HB
    Res Commun Chem Pathol Pharmacol; 1981 Aug; 33(2):381-4. PubMed ID: 6272381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Modern representations of multiple forms of cyclic nucleotide phosphodiesterases in mammalian tissues].
    Medvedeva MV
    Biokhimiia; 1995 Mar; 60(3):364-86. PubMed ID: 7734612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclic nucleotide changes in X-irradiated synchronized Tetrahymena.
    Charp PA; Whitson GL
    Radiat Res; 1978 May; 74(2):323-34. PubMed ID: 208095
    [No Abstract]   [Full Text] [Related]  

  • 15. Relationship between inhibition of cardiac muscle phosphodiesterases, changes in cyclic nucleotide levels, and contractile response for CI-914 and other novel cardiotonics.
    Weishaar RE; Quade MM; Schenden JA; Evans DB
    J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(6):551-64. PubMed ID: 3003170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of cyclic nucleotide phosphodiesterase activity in rhesus fetal muscle.
    Beatty CH; Herrington PT; Bocek RM
    Biol Neonate; 1977; 32(1-2):33-42. PubMed ID: 198031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Kinetic properties and regulation of cyclic nucleotide phosphodiesterases in lymphoid cells].
    Azhaeva EV; Severin ES
    Bioorg Khim; 1987 Sep; 13(9):1157-63. PubMed ID: 2827690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic nucleotide metabolism in the mouse spleen after treatment with tilorone hydrochloride.
    Römer W; Zschiesche W
    Acta Biol Med Ger; 1979; 38(5-6):791-4. PubMed ID: 43058
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibitory and activators of cyclic nucleotide phosphodiesterase.
    Chasin M; Harris DN
    Adv Cyclic Nucleotide Res; 1976; 7():225-64. PubMed ID: 188316
    [No Abstract]   [Full Text] [Related]  

  • 20. [Changes in the activity of cyclic adenosine monophosphate metabolism enzymes in myocardial hypertrophy and after exposure to hyperbaric oxygenation].
    Miroshnichenko VP; Zubovskaia AM; Grigorovich IuA; Demurov EA; Koloskov IuB
    Vopr Med Khim; 1981; 27(1):112-5. PubMed ID: 6258317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.